Objectives: Define cannabis components; map the anatomical distribution of the Endocannabinoid
System (ECS); evaluate Cytochrome P450 (CYP450) metabolic pathways.
Content Outline: Phytocannabinoids (THC, CBD, CBG, CBN) vs. endogenous ligands (Anandamide, 2-
AG). Functional mechanics of $CB_1$ and $CB_2$ receptors. Hepatic clearance profiles and high-risk
drug interactions (e.g., Warfarin, Clobazam).
Activities: High-definition schematic video lectures; guided independent analysis of peer-reviewed
pharmacokinetic data.
Course Content
Module 1: Lesson 1
You don't currently have access to this content
Module 1: Lesson 2
You don't currently have access to this content
Question 1.1: Drug-Drug Interactions (Anticoagulation)
You don't currently have access to this content
Question 1.2: Receptor Pharmacodynamics (THC vs. CBD)
You don't currently have access to this content